Long-term utilization and benefit of luspatercept in transfusion-dependent, erythropoiesis-stimulating agent-refractory or -intolerant patients with lower-risk myelodysplastic syndromes with ring sideroblasts.
作者信息
Platzbecker Uwe, Santini Valeria, Komrokji Rami S, Zeidan Amer M, Garcia-Manero Guillermo, Buckstein Rena, Miteva Dimana, Keeperman Karen, Holot Natalia, Nadal Jose Alberto, Lai Yinzhi, Vodala Sadanand, Rosettani Barbara, Giuseppi Ana Carolina, Yucel Aylin, Fenaux Pierre
机构信息
Medical Clinic and Policlinic 1, Hematology and Cellular Therapy, University Hospital Leipzig, Leipzig, Germany.
MDS Unit, AOU Careggi, University of Florence, Florence, Italy.
出版信息
Leukemia. 2023 Nov;37(11):2314-2318. doi: 10.1038/s41375-023-02031-7. Epub 2023 Sep 26.
Abstract
摘要
Zotero 插件